Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.04B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$593M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$387M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$354M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$296M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$289M |
| 3 |
Morgan Stanley
MS
|
+$253M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
Alibaba
BABA
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.49% |
| 2 | Technology | 13.15% |
| 3 | Healthcare | 7.94% |
| 4 | Communication Services | 7.92% |
| 5 | Industrials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
PUT
Toronto Dominion Bank
TD
$204B
| $221M | 0.06% |
3,150,200
+97,400
| +3% | +$6.81M |
|
277
Unilever
UL
$133B
| $220M | 0.06% |
3,342,888
+99,342
| +3% | +$6.61M |
|
278
Ameriprise Financial
AMP
$49.9B
| $219M | 0.06% |
880,370
-217,135
| -20% | -$54.7M |
|
|
SCHW
279
Charles Schwab
SCHW
$189B
| $219M | 0.06% |
3,005,340
+489,219
| +19% | +$34.6M |
|
280
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.75B
| $218M | 0.06% |
2,037,974
+210,345
| +12% | +$21.8M |
|
281
Stantec
STN
$8.47B
| $216M | 0.06% |
4,849,215
-252,780
| -5% | -$11.4M |
|
282
UBS Group
UBS
$177B
| $216M | 0.06% |
14,104,363
-2,620,201
| -16% | -$41.4M |
|
283
Vertex Pharmaceuticals
VRTX
$133B
| $216M | 0.06% |
1,072,141
+230,563
| +27% | +$48.2M |
|
284
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $215M | 0.06% |
1,600,563
-39,305
| -2% | -$5.18M |
|
285
American Express
AXP
$232B
| $215M | 0.06% |
1,300,064
+157,990
| +14% | +$24.7M |
|
286
CAE Inc. Common Shares
CAE
$8.9B
| $214M | 0.06% |
6,950,305
-706,331
| -9% | -$21.6M |
|
287
Microchip Technology
MCHP
$43.1B
| $214M | 0.06% |
2,855,274
+349,190
| +14% | +$26.6M |
|
288
Incyte
INCY
$24.5B
| $213M | 0.06% |
2,529,498
+254,056
| +11% | +$21.2M |
|
289
Credicorp
BAP
$29.6B
| $209M | 0.06% |
1,722,833
+25,686
| +2% | +$3.36M |
|
290
Idexx Laboratories
IDXX
$45B
| $207M | 0.06% |
328,125
-40,620
| -11% | -$22.4M |
|
291
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $205M | 0.05% |
2,240,809
-158,055
| -7% | -$14.5M |
|
292
CALL
Broadcom
AVGO
$1.98T
| $203M | 0.05% |
4,263,000
+3,513,000
| +468% | +$163M |
|
293
ARK Innovation ETF
ARKK
$6.44B
| $203M | 0.05% |
1,553,321
-59,220
| -4% | -$6.9M |
|
|
FISV
294
Fiserv Inc
FISV
$27.4B
| $202M | 0.05% |
1,887,827
-932,069
| -33% | -$108M |
|
295
Micron Technology
MU
$1.03T
| $202M | 0.05% |
2,372,333
-534,124
| -18% | -$45.1M |
|
296
Old Dominion Freight Line
ODFL
$44.1B
| $202M | 0.05% |
1,588,188
+159,824
| +11% | +$20.5M |
|
297
PUT
JPMorgan Chase
JPM
$971B
| $201M | 0.05% |
1,290,800
-358,400
| -22% | -$56.3M |
|
298
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $200M | 0.05% |
1,955,054
+387,782
| +25% | +$39.7M |
|
299
Zebra Technologies
ZBRA
$17.9B
| $200M | 0.05% |
377,626
-24,897
| -6% | -$12.4M |
|
300
iShares MSCI Emerging Markets ETF
EEM
$30.4B
| $198M | 0.05% |
3,599,161
-1,092,803
| -23% | -$59.4M |
|
Similar funds
Royal Bank of Canada's Q2 2021 Portfolio in Review
As of Q2 2021, Royal Bank of Canada held 8,046 positions worth $376B, up 9.1% from $345B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2021 filing shows 552 new, 3,617 increased, 2,728 reduced and 449 closed positions. Its largest new stake was Coinbase: 130,336 shares worth $33M. The largest sale was GSK, an estimated $296M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- Royal Bank of Canada's largest Q2 2021 buy was Coinbase: 130,336 shares worth $33M.
- Royal Bank of Canada added most to Philip Morris in Q2 2021, an estimated $1.04B increase.
- Royal Bank of Canada's biggest Q2 2021 reduction was GSK, cutting an estimated $296M.
- Royal Bank of Canada fully exited RealPage, Inc. in Q2 2021, selling an estimated $95.4M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $376B portfolio in Q2 2021.
- Royal Bank of Canada opened 552 new positions and closed 449 in Q2 2021.
- Royal Bank of Canada's portfolio value rose 9.1% quarter-over-quarter to $376B.
Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.